Given the higher levels of reactive oxygen species (ROS) in cancer cells and their dependency on SLC7A11, targeting SLC7A11 to deplete cyst(e)ine could render cancer cells more susceptible to further oxidative stress. Here, SLC7A11 is linked to cancer.